Antonio Pequeño IV

Staff Reporter (Health care, law, finance)

Email: apequeno@sfvbj.com
Phone: 818-316-3121 Extension: 112

Recent Stories

Lancaster Urgent Care Center Wins Design-Build Award

High Desert Mental Health Urgent Care Center was among the award winners when the Design-Build Institute of America announced its nationwide 2021 Design-Build Project/Team Awards.

$8 Million VC For RentSpree

TECHNOLOGY: Tenant screening software firm plans to expand.

Tenant screening company raises $8 million in venture capital.

TV Series Tells of Valley ‘Unicorn’

Calabasas-based comedy tackles diversity in the fashion industry.

Calabasas-based television show tackles diversity in the fashion industry.

Too Little Lead Time Given for Mask Mandate

REGULATION: Business groups say implementation stressed restaurants, retailers.

Business groups call attention to latest mask mandate.

$126 Million Expansion

Takeda has green vision for Thousand Oaks facility.

Takeda Pharmacuetical broke ground on $126 million expansion in Thousand Oaks.

Eyenuk Secures $6.2 Million for AI

Marketing to accelerate for diabetic retinopathy testing.

Artificial intelligence medical technology company Eyenuk recently secured $6.2 million in funding from a financing round led by Axa Investment Managers.

Capsida Opens Gene Therapy Plant

Thousand Oaks facility will hasten drug development.

Biotechnology company Capsida Biotherapeutics opened its gene therapy manufacturing facility in Thousand Oaks just two years after the company’s founding.

Amgen Appoints Former Medtronic CEO Omar Ishrak to Board

Amgen Inc. announced Thursday the appointment of S. Omar Ishrak, former chairman and chief executive of Medtronic, to its board effective immediately.

‘Best Hospital’ Ranking Names Six in Valley Region

Six San Fernando Valley region hospitals were named in U.S. News & World Report’s “Best Hospitals” for 2021-2022.

Amgen to Acquire Teneobio for $900 Million Cash

Thousand Oaks-based Amgen Inc. announced it will acquire private biotechnology company Teneobio in exchange for $900 million in cash.

More stories >>